Effect of Dilatation and Curettage on the Endometrial Receptivity

Effect of dilatation and curettage on the endometrial receptivity and pregnancy outcome in patients with recurrent implantation failure

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Embryo Implantation

Age range

25 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ain Shams University Maternity Hospital

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All the patients had at least 3 failed trials of IVF-ET with day 5 fresh blastocyst transferred
At least 10 high-grade embryos were obtained in the previous trials
Level of AMH more than or equal 1.1 ng/ml.
Age: Less than or equal to 35 years

Exclusion criteria

Patients with uterine pathology e.g. myoma , Asherman syndrome, Septum ,adenomyosis
Hydrosalpinx
Endometriosis
patients with diagnosed autoimmune diseases affecting pregnancy e.g. S.L.E.

Treatment and study plan

D&C

Procedure

Dilatation and curettage

ICSI

Procedure

Intra Cytoplasmic Sperm Injection

Primary outcomes

Live Birth Rate

Time frame: 9 months

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Effect of Dilatation and Curettage on the Endometrial Receptivity and Pregnancy Outcome in Patients With Recurrent Implantation Failure

Important dates

Study start: 2018
Primary completion: 2019
Study completion: 2019
First posted: Apr 2, 2018
Registry last updated: Jan 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed